Please login to the form below

Slide Deck: Kinetic: A new approach shaping the future of advisory boards

How many times have we attended meetings that have little direction, or no clear objectives and left feeling disinterested and disengaged? Our “Kinetic” consulting approach is set to change all of that by providing insight, challenging objectives and creating energy and engagement to deliver real improved tangible outputs to your meetings.

On what can feel like a daily basis, our clients approach us to support with the delivery and execution of advisory boards around the world for a variety of subjects. These range from clinical trial design to educational needs assessment, branding to market access. According to a recent study by the Business Development Bank of Canada (BDC), advisory boards can lead to huge gains including higher sales and productivity (Advisory boards: An untapped resource).

To ensure that these meetings deliver value for pharma it’s important to begin by asking “What is the objective of this meeting and how will this impact the ongoing programme?”. Advisory boards are a crucial part of the product development lifecycle for pharma; providing expert external advice and acting as sounding boards for strategic decisions.

So what should an effective advisory board look like? How would you answer these questions...

Do you have clear objectives? 
Do you have the right attendees?
Who will facilitate the meeting?
What will the format be?
What is the bigger picture?

Click here and take a look at our detailed slide deck to understand more about our Kinetic approach to advisory boards.

2nd September 2016



Company Details


Contact Website

Ashfield House
Resolution Road
Ashby de la Zouch
LE65 1HW

Latest content on this profile

Ashfield’s highlights from eyeforpharma Barcelona 2018
This week we were delighted to attend eyeforpharma Barcelona 2018 as global sponsors, where we ran a communications strategy workshop using our new Humanise framework and Nagore Fernandez, Head of Clinical Services for EUCAN, hosted part of the Commercial track.
Ashfield wins Best Newcomer at the Pf Awards 2018
We are thrilled to announce that Zuchaela Smylie, from Ashfield, won Best Newcomer at the 2018 Pf Awards, the largest pharmaceutical sales awards in the UK. The awards ceremony took place on Thursday, 9 March at The Lancaster Hotel in London.
“It is evident that meeting face-to-face is still highly valued in the digital age”
Attending a scientific congress or meeting overtakes professional journals and publications as the educational channel of choice for Healthcare Professionals – according to findings of new study
Ashfield to present at the Orphan Drugs for Rare Diseases Summit
Ashfield has a breadth of experience with orphan drugs and we are passionate about helping to improve the lives of people living with rare diseases. We are delighted to be sponsoring and presenting at the ‘Orphan Drugs for Rare Diseases’ event 22-23 March in Berlin.
Addressing the biggest challenges for rare disease communities
Each year, Rare Disease Day takes place worldwide on the last day in February. The main objective of Rare Disease Day is to raise awareness amongst the general public, the healthcare industry and decision-makers about rare diseases and their impact on patients' lives.
Humanise is our strategic approach to healthcare communications. It’s based on the need to understand. It looks at the emotions that make us human. It examines the feelings we have as individuals. It defines the behaviours we show as people.